Prosperity Wealth Management Inc. acquired a new stake in shares of iRadimed Corporation (NASDAQ:IRMD - Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 6,595 shares of the medical equipment provider's stock, valued at approximately $346,000. Prosperity Wealth Management Inc. owned about 0.05% of iRadimed at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. US Bancorp DE boosted its stake in iRadimed by 476.6% in the 4th quarter. US Bancorp DE now owns 617 shares of the medical equipment provider's stock worth $34,000 after purchasing an additional 510 shares in the last quarter. Huntington National Bank raised its holdings in shares of iRadimed by 34.0% in the fourth quarter. Huntington National Bank now owns 1,993 shares of the medical equipment provider's stock worth $110,000 after buying an additional 506 shares during the last quarter. State of Wyoming acquired a new stake in shares of iRadimed during the fourth quarter worth $149,000. Avantax Advisory Services Inc. purchased a new stake in shares of iRadimed during the fourth quarter valued at $217,000. Finally, Bessemer Group Inc. grew its holdings in shares of iRadimed by 9.6% during the fourth quarter. Bessemer Group Inc. now owns 4,143 shares of the medical equipment provider's stock valued at $228,000 after buying an additional 362 shares during the last quarter. Institutional investors and hedge funds own 92.34% of the company's stock.
iRadimed Stock Performance
NASDAQ IRMD traded down $0.21 during trading hours on Friday, reaching $58.24. The stock had a trading volume of 106,375 shares, compared to its average volume of 43,355. iRadimed Corporation has a 52-week low of $42.34 and a 52-week high of $63.29. The stock has a fifty day moving average of $54.75 and a 200 day moving average of $55.05. The stock has a market cap of $740.81 million, a P/E ratio of 37.57 and a beta of 0.92.
iRadimed Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Tuesday, May 20th were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.17%. The ex-dividend date of this dividend was Tuesday, May 20th. iRadimed's payout ratio is 43.87%.
Analyst Ratings Changes
Separately, Wall Street Zen upgraded iRadimed from a "buy" rating to a "strong-buy" rating in a research note on Tuesday, May 6th.
View Our Latest Analysis on iRadimed
iRadimed Profile
(
Free Report)
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.
Featured Articles
Before you consider iRadimed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and iRadimed wasn't on the list.
While iRadimed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
